Fig.4.

Drug release profile. A. In vitro SSD release from PCL/SSD nanofibrous mat, B. Antibacterial test for PCL/SSD, 1 and 3 are PCL mat containing SSD, and 2 and 4 are PCL mat. B. is Staphylococcus aureus and C. is Pseudomonas aeruginosa. MTT assay for PCL and PCL/SSD nanofibrous mat, D. Differences between two nanofibrous mat were not significant, E. Attachment of cells on PCL nanofibrous mat (scale bar: 50 µm), and F. PCL/SSD nanofibrous mat are shown (scale bar: 50 µm).

SSD; Silver sulfadiazine, PCL; Polycaprolactone, and MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.